Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Apr 15, 2021; 13(4): 265-278
Published online Apr 15, 2021. doi: 10.4251/wjgo.v13.i4.265
Published online Apr 15, 2021. doi: 10.4251/wjgo.v13.i4.265
Table 2 Expression profiles of primary gastric cancer and remnant gastric cancer patients
Primary GC | Remnant GC | ||
Variables | n 284 (%) | n 40 (%) | P value |
EBV | 0.039a | ||
Negative | 254 (89.4) | 31 (77.5) | |
Positive | 30 (10.6) | 9 (22.5) | |
MSI/MSS status | 0.362 | ||
MSS | 224 (78.9) | 29 (72.5) | |
MSI | 60 (21.1) | 11 (27.5) | |
p53 | 0.121 | ||
Normal | 177 (62.8) | 20 (50) | |
Aberrant | 105 (37.2) | 20 (50) | |
E-cadherin | 0.565 | ||
Normal | 255 90.7) | 35 (87.5) | |
Loss of expression | 26 (9.3) | 5 (12.5) | |
Profiles with altered expression (EBV, MSI, E-cadherin, p53) | < 0.001a | ||
One or none | 261 (91.9) | 26 (65) | |
Two or more | 23 (8.1) | 14 (35) | |
Number of altered profiles | - | ||
0 | 86 (30.3) | 13 (32.5) | |
1 | 175 (61.6) | 13 (32.5) | |
2 | 23 (8.1) | 11 (27.5) | |
3 | 0 (0) | 2 (5) | |
4 | 0 (0) | 1 (2.5) |
- Citation: Ramos MFKP, Pereira MA, Cardili L, de Mello ES, Ribeiro Jr U, Zilberstein B, Cecconello I. Expression profiles of gastric cancer molecular subtypes in remnant tumors. World J Gastrointest Oncol 2021; 13(4): 265-278
- URL: https://www.wjgnet.com/1948-5204/full/v13/i4/265.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i4.265